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Suicide completion in secondary mental
healthcare: a comparison study between
schizophrenia spectrum disorders and all
other diagnoses
Javier-David Lopez-Morinigo1*, Andrea C Fernandes2, Chin-Kuo Chang2, Richard D Hayes2, Matthew Broadbent2,
Robert Stewart2, Anthony S David1 and Rina Dutta2
Abstract
Background: Suicide completion is a tragic outcome in secondary mental healthcare. However, the extent to which
demographic and clinical characteristics, suicide method and service use-related factors vary across psychiatric
diagnoses remains poorly understood, particularly regarding differences between ‘schizophrenia spectrum disorders
(SSD)’ and ‘all other diagnoses’, which may have implications for suicide prevention in high risk groups.
Methods: 308 patients who died by suicide over 2007–2011 were identified from the South London and Maudsley
NHS Foundation Trust Biomedical Research Centre Case Register. Demographic, clinical, services use-related factors, ‘full
risk assessment’ ratings and the Health of the Nation Outcome Scale (HONOS) scores were compared across psychiatric
diagnoses. Specifically, differences between patients with and without SSD were investigated.
Results: Patients with SSD ended their lives at a younger age, were more frequently of Black ethnicity and had
higher levels of social deprivation than other diagnoses. Also, these patients were more likely to have HONOS and ‘risk
assessment’ completed. However, patients who had no SSD scored significantly higher on ‘self-injury’ and ‘depression’
HONOS items and they were more likely to have the following ‘risk assessment’ items: ‘suicidal ideation’, ‘hopelessness’,
‘feeling no control of life’, ‘impulsivity’ and ‘significant loss’. Of note, ‘disengagement’ was more common in patients
with SSD, although they had been seen by the staff closer to the time of suicide than in all-other diagnoses. Whilst
‘hanging’ was the most common suicide method amongst patients with non-SSD, most service users with a SSD
diagnosis used ‘jumping’ (from heights or in front of a vehicle).
Conclusions: Suicide completion characteristics varied between SSD and other diagnoses in patients receiving
secondary mental healthcare. In particular, although clinicians tend to more frequently recognize suicide risk as
a focus of concern in patients who have SSD, who are therefore more likely to have a detailed risk assessment
documented; ‘known’ suicide risk factors appear to be more relevant in patients with non-SSD. Hence, the classic
suicide prevention model might be of little use for SSD.
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Background
Suicide is a serious international public health problem.
Every year almost one million people die by suicide
around the world [1]. Of note, suicide has become espe-
cially concerning among young people as one of the
three leading causes of death in the most economically
productive age group (15–44 years) and the second
leading cause of death in 15–19 year olds [2]. Since
2008, suicide prevention has become a major priority
within World Health Organization mental health policies
[3]. However, suicide prevention strategies have yielded
mixed results so far (see [4]).
Recent literature on suicide seems to support a ‘sui-
cidal spectrum’ ranging from suicidal ideation to suicide
completion, with decreasing prevalence and increasing
lethality [5]. With regard to suicide completion, psycho-
logical autopsy studies have revealed that about 90% of
people who killed themselves had a ‘psychiatric disorder’,
contributing to 47-74% of the population risk of suicide,
and with half of suicide completers meeting criteria
for depression [6,7]. In other words, the presence of a
psychiatric condition appears to be the strongest risk
known factor for suicide [6]. It could therefore be envisaged
that better management of mental disorders might reduce
suicide rates. More specifically, secondary mental health
services may play a crucial role in ‘suicide prevention’ [1].
While a list of risk factors have been strongly associated
with ‘suicidal behaviour’, it remains unclear the extent to
which such ‘known’ risk factors vary across psychiatric
diagnoses [8]. In particular, a better understanding of asso-
ciations between risk factors and diagnoses may lead to
the development and implementation of diagnosis-driven
suicide prevention strategies in secondary mental health
services. For instance, limiting access to instruments of
suicide has been demonstrated to reduce suicide rates at a
population level (e.g. [9,10]). However, it remains unclear
whether there are specific associations of psychiatric diag-
noses with suicide completion methods [11].
Suicide has been found to be the largest single cause
of excess mortality in schizophrenia [12,13]. However,
the rate of suicide in schizophrenia has been recently
demonstrated to be lower, from 2% [14] to 5% [15], than
the ‘classic’ figure of 10% [16,17]. Of note, while some
recognised general suicide risk factors have been repli-
cated in schizophrenia patients such as being male, living
alone and hopelessness; specific suicide risk factors have
also been linked to schizophrenia such as lower treatment
adherence [18]. Patients with schizophrenia tend not to
report suicidal ideation [19], which is a common suicide
risk factor for most other psychiatric conditions [4]. Also,
suicide risk assessment in schizophrenia remains under-
utilized [20]. It therefore seems that the classic suicide
prevention model has been less helpful in schizophrenia
spectrum disorders than in other diagnoses. Specific
suicide completion characteristics in patients with schizo-
phrenia and related disorders in comparison to other
diagnoses have not been investigated as fully.
In the UK, over the last two decades the Department
of Health has aimed to reduce suicides at a national level
[21]. In keeping with this, instruments such as the Health
of the Nation Outcome Scale (HoNOS) [22] and structured
clinical risk assessments have been strongly recommended
[23] and widely used by mental health teams. The extent to
which the ‘known’ risk factors for suicide evaluated by such
instruments vary across psychiatric diagnoses in patients
who took their lives, is also unknown.
We aimed to investigate differences across diagnoses in
a sample of patients receiving secondary mental health-
care from teams supervised by Consultant Psychiatrists
(i.e. not those treated solely by general practitioners
(family physicians) in primary care) who went on to die
from suicide. Specifically, sociodemographic and clinical
variables, including HoNOS and ‘risk assessment’ ratings
and ‘service use’-related factors, and suicide methods
were compared between patients with and without
schizophrenia spectrum disorders (SSD) who all died
by suicide. Hence, our methodology was not designed
to test potential suicide risk factor differences across
diagnoses since all the participants had the same fatal
outcome. Instead our research question was to investigate
differences between patients with and without SSD in a
sample of secondary mental health service users who all
ended their lives.
Methods
Sample
The sample comes from the South London and Maudsley
(SLaM) Biomedical Research Centre (BRC) Case Register.
SLaM is an NHS Trust which provides secondary mental
health care to four boroughs in South-East London (UK):
Lambeth, Southwark, Lewisham and Croydon. Approxi-
mately 1.23 million inhabitants reside in this geographic
catchment area, which as a whole was found to be com-
parable with other populations of London in terms of age,
gender, education and socio-economic status distributions
[24]. Fully-electronic health records have been in use
across all SLaM services since 2006, and in 2007–08 the
Clinical Record Interactive Search (CRIS) system was built
which renders de-identified copies of these available for
research use with appropriate governance structures [24].
Under UK law, anonymised data can be analysed without
prior consent, and CRIS has received ethical approval in
this respect as a data resource for secondary analyses from
the Oxfordshire Research Ethics Committee C (reference:
08/H0606/71 + 5), currently accessing data on over 250,000
patients. The same Research Ethics approval also covers
the pseudonymised linkage between CRIS data and those
from the Office for National Statistics (ONS) in March
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2012 [25] which registers all deaths in the UK and the offi-
cial cause of death, including suicide and the method of
suicide according to ICD-10 classification [26].
The study sample for our analysis was composed of
those patients who were ‘active’ to SLaM (i.e. had at least
one face-to-face contact with a clinical member of staff ) at
any point before 31st December 2011, and who had died
by suicide (according to the ONS [25] certificate of death)
during the period 1st January 2007 to 31st December
2011, including those with an ‘undetermined cause of
death’ (ICD-10 Y codes) [26]. Of note, in the UK most
‘open verdicts’ are very likely to be deaths by suicide as
the coroner, who under UK law determines the cause of
death, is required to provide evidence of suicide intent
‘beyond reasonable doubt’ [27].
Measures
Demographic and clinical variables
Date of birth, gender, ethnicity, ‘hearing, visual or mobility
impairments’ (recorded as present/absent) and ICD-10
diagnosis are compulsory fields in the source clinical
records system and were analysed. Social deprivation
was estimated with the ‘Index of Multiple Deprivation’
(IMD). In particular, area-level deprivation scores were
available through an anonymous link created in CRIS
between lower super output area residence code of the
latest permanent address (a geographic unit comprising
approximately 400 households) and summary data for
that area from 2001 UK Census output. The Index of
Multiple Deprivation is derived from seven domains:
income, employment, health, education, housing and
services, crime and environment [28].
Diagnoses
Distributions and labelling of ICD-10 [26] primary
diagnoses in the sample are summarized in Table 1. In
particular, ICD-10 diagnoses [26] were made by the
treating consultant psychiatrist, including the use of the
OPCRIT system [29] for those patients with psychotic
disorders, which has been demonstrated to have high
reliability across the Trust psychiatrists [30], who are
mandatorily trained in the use of this tool. As a result,
those patients who were just seen on one occasion such as
a single presentation to A&E or one outpatient appoint-
ment were more likely not to be diagnosed as reported
below. For analyses described here, categories were
hierarchically created from ICD-10 codes [26]. Thus,
only one of the following exclusive diagnostic categories
were recorded if the patient had received more than one
ICD-10 primary diagnosis: ‘F2’ – ‘schizophrenia spectrum
disorder’ (SSD); ‘F31 and F32.3’ – ‘Affective Psychosis’;
‘F32.1, F32.2, F33, F34 and F4’ – ‘Mood disorder/Neuroses’;
‘F0 and F1’ – ‘Organic/Drugs’; ‘F5, F6 and the remaining
categories’ were grouped as ‘All other diagnoses’. 94
remaining patients (30.5%) were labelled as ‘Diagnosis
Unknown’ because they either had a F99 or Z71.1 ICD-10
diagnosis or no diagnosis was recorded. Patients with two
or more ICD-10 [26] primary diagnoses over time were
included in only one of the above categories according to
such hierarchy. For instance, a patient with two primary
ICD-10 diagnoses such as F2 and F0 was classified as SSD.
Whilst many patients with SSD have other comorbidities
such as cannabis misuse [31], given the higher stability of
schizophrenia diagnosis over time [32], we chose this cat-
egory as the first in our hierarchical system. This allowed
us to create two clinically meaningful categories to com-
pare: those patients with SSD and those with non-SSD.
Suicide ascertainment and suicide method
Suicide method was ascertained from that recorded in
the ONS Certificate of Death [25] (ICD-10 codes) [26]
and the following groups were considered: hanging -
X83.8, drowning - X71, cutting - X78, poisoning - X64
and Y1, jumping (either from high place or in front of a
vehicle) - X80, X81, burning - X76, X77 and undetermined
cause of death - Yxx.
Health of the Nation Outcome Scale (HoNOS)
The Health of the Nation Outcome Scale (HoNOS) has
been a widely used outcome measure in British mental
health services since its introduction in the 1990s, found
to be a reliable and valid instrument to assess clinical
outcomes, and to have easy applicability to clinical settings
Table 1 Diagnoses
ICD-10 diagnosis No. completed suicide Diagnostic categories
F2 ever 54 Schizophrenia
spectrum disorder
54 (17.5%)
Non-F2 197
F00-09 10 Organic/Drugs
F10-19 35 45 (14.6%)
F31 17 Affective Psychoses
F32.3 6 23 (7.5%)
F32, F33, F34 38 Mood Disorders
and Neuroses
F40-48 21 59 (19.2%)
F50-59 1 Others
F60-69 10 33 (10.7%)
Others 22
F99 16 Diagnosis ‘unknown’
Z71.1 21 94 (30.5%)
ICD-10 diagnosis
unrecorded
57
Total 308 308
ICD-10: International Classification of Mental and Behavioural Disorders [24].
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[22]. HoNOS is formed of 12 items which assess psychi-
atric symptoms (e.g. depressed mood or hallucinations),
alcohol/drugs use and social needs such as relationship
problems or daily living activities. Each item is scored on a
Likert scale from 0 (absent) to 4 (maximum severity), and
the 12 scores are summed to create total scores, i.e. the
higher the score, the more complex/severe the case.
The last HoNOS recorded for each patient was used for
the purposes of this study.
Risk assessment
‘Full risk assessment’ is a compulsory target across the
Trust when ‘high risk’ is determined from a ‘brief risk
assessment’, which is mandatory for all active cases. All
patients who have been seen on at least one occasion
by a member of the staff have a ‘brief risk assessment’
documented, which is a narrative record of the patient’s
risk: i) to one’s self; ii) to others and iii) from others. If
the patient is deemed at ‘high’ risk in any of these
domains, a ‘full risk assessment’ needs to be completed,
which consists of a structured assessment taking the
form of present/absent tick-boxes enquiring about widely
recognised risk factors for three major clusters: suicide,
violence and self-neglect. For this study, only suicide risk
assessment was taken into account, which is composed of
15 items (shown in Table 2) including suicidal history,
hopelessness, alcohol misuse, living alone or disengage-
ment. Positive responses can be summed to create total
scores, i.e. the higher the score the greater the suicide risk
[33]. The most recent full risk assessment was considered
for these analyses.
Statistical analyses
Distributions of continuous variables were inspected by
histograms and parametric and non-parametric tests
were used in order to examine differences across the above
‘diagnostic categories’ with regard to demographic and
clinical variables. Post-hoc analyses investigated inter-
groups differences. People dying from suicide with/with-
out SSD were compared in the following respects: i) on
demographic and clinical variables using student t tests,
Mann–Whitney U tests and Chi-square tests, as appropri-
ate; ii) on suicide methods, calculating odds ratios and
adjusting for age at the time of death and ethnicity; iii) on
HoNOS, where completed, both individual HoNOS item
(Mann–Whitney-U) and total scores (student t-test); iv)
on full risk assessment scores for the 40 (13%) patients
with this information (t-test). All analyses were conducted
using SPSS version 20.0 (SPSS Inc, Chicago, Il, USA).
Results
Of 120,216 SLaM ‘active’ service users until the 31st
December 2011, 308 who died by suicide over 2007–2011
were identified from the SLaM BRC CRIS.
Table 2 Risk Assessment: Completion rates, individual items and total scores comparison in SSD and non-SSD suicide
completers
Completion rate
40 (13.0%)
Total sample
N = 40
SSD N = 19
(19/54 = 35.2%)
non-SSD N = 21
(21/254 = 8.3%)
ORs (95% CIs)
6.02 (2.94-12.31)
Fisher’s exact
test P < 0.001
Individual items p-value
Suicidal History 26 (65) 11 (57.9) 15 (71.4) 0.55 (0.15-2.05) ns
Lethal Method 15 (37.5) 5 (26.3) 10 (47.6) 0.39 (0.10-1.49) ns
Plan to end life 8 (20) 2 (10.5) 6 (28.6) 0.29 (0.05-1.68) ns
Suicidal ideation 16 (40) 4 (21) 12 (57.1) 0.2 (0.05-0.81) 0.027
Hopelessness 18 (45) 4 (21) 14 (66.6) 0.13 (0.03-0.55) 0.005
Distress 17 (42.5) 7 (36.8) 10 (47.6) 0.64 (0.18-2.27) ns
No control of life 15 (37.5) 4 (21) 11 (52.4) 0.24 (0.06-0.98) 0.038
Alcohol Misuse 11 (27.5) 7 (36.8) 4 (19.0) 2.47 (0.59-10.40) ns
Impulsivity 18 (45) 5 (26.3) 13 (61.9) 0.22 (0.06-0.84) 0.031
Living alone 18 (45) 8 (42.1) 10 (47.6) 0.80 (0.23-2.80) ns
Poor physical health 9 (22.5) 4 (21) 5 (23.8) 0.85 (0.19-3.79) ns
Significant loss 18 (45) 5 (26.3) 13 (61.9) 0.22 (0.06-0.84) 0.031
Disengagement 9 (22.5) 7 (36.8) 2 (9.5) 5.54 (0.98-31.25) 0.060
Recent Discharge from hospital 11 (27.5) 5 (26.3) 6 (28.6) 0.89 (0.22-3.59) ns
Family History 0 0 (0) 0 (0) n/a ns
Total score 4.11 ± 2.88 6.24 ± 2.19 0.012
SSD: schizophrenia spectrum disorder; OR: odds ratio; CI: confidence interval; ns: non-significant; in bold: statistically significant differences.
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Sociodemographic and clinical characteristics of the sample
As shown in Table 1, 54 patients (17.5%) had a diagnosis
within the schizophrenia spectrum (F2-ICD10). ‘Mood
disorders’, including ‘affective psychosis’ (23 patients,
7.5%) and ‘non-psychotic mood disorders and neuroses’
(59, 19.2%), was the most common diagnosis. Also, 45
suicide completers (14.6%) were diagnosed with ‘organic
disorders or drugs dependence’ and 33 marginal cases
(10.7%) had ‘other’ (known) diagnosis such as Obsessive-
Compulsive Disorder (OCD), Attention Deficit Hyper-
activity Disorder (ADHD) and Autism Spectrum Disorders
(ASD). Of note, 94 patients (30.5%) had no recorded
diagnosis, which in most cases (69, 73.4%) was related
to having had just one face-to-face contact with the
staff (e.g. a single presentation to A&E).
Sociodemographic and clinical characteristics are com-
pared across multiple diagnoses in Table 3, and specifically
between those with and without SSD in Table 4. No
diagnostic differences were observed in gender; however,
age at the time of suicide was younger in those with
SSD than the remainder. There were significant group
differences in ethnicity across suicide completers’ diagnoses
with Black ethnicity more frequent in patients presenting
with SSD. Although there were no significant differences in
IMD scores across diagnoses (Table 3), these were
higher in SSD compared to the remainder. Hearing, visual
or mobility impairment did not vary significantly across
all diagnoses but mobility impairment was more common
in SSD than the remainder. SSD cases had received longer
duration of care from the Trust teams and had been
seen by a member of the staff substantially more recently
before the suicide event.
Suicide method
As shown in Tables 5 and 6, ‘hanging’ was the most com-
mon suicide method in the sample overall (131, 42.5%).
SSD suicide cases had more frequently utilized ‘jumping’,
while ‘hanging’ was significantly more frequent among the
remainder. There were no suicides by firearms.
Health of the Nation Outcome Scale (HoNOS)
116 suicide completers (37.6%) had at least one HoNOS
completed. Completion rates differed across diagnoses:
83.3% of those with SSD; 35.0% of the remainder (OR =
12.9, 95% CI 6.0-27.7, p < 0.001). On individual items,
patients with SSD scored significantly higher on ‘hallucina-
tions & delusions’, while subjects with non-SSD had higher
scores on ‘depressed mood’ and ‘self-injury’ (Table 7).
Full risk assessment
As described in Table 2, only 40 suicide completers
(13%) had at least one full risk assessment completed:
Table 3 Demographics, clinical and service use-related factors for suicide completers across diagnoses
Total
sample
308
Schizophrenia
spectrum disorder
54 (17.5)
Affective
psychosis
23 (7.4)
Mood disorders/
neuroses
62 (20.1)
Organic/
drugs
45 (14.6)
Other
diagnoses
30 (9.7)
Diagnosis
unknown
94 (30.5)
p-value
Age at the time of death 42.7 ± 14.0 39.3 ± 11.9 49.3 ± 14.2 47.0 ± 16.5 44.7 ± 14.0 39.3 ± 13.4 40.4 ± 12.5 0.040
Gender (males) 211 (68.5) 38 (70.3) 10 (43.5) 40 (64.5) 36 (80.0) 19 (63.3) 68 (72.3) 0.052
Ethnicity
White British 157 (51) 22 (40.7) 18 (78.3) 45 (72.6) 30 (75.0) 13 (4.3) 29 (30.8) < 0.001
Other white background 30 (9.7) 4 (7.4) 1 (4.3) 3 (4.8) 8 (16.6) 2 (6.6) 12 (12.7) ns
South Asian 5 (1.6) 2 (3.7) 0 (4.3) 2 (3.2) 0 (0) 0 (0) 1 (1.0) ns
African and
other black
25 (8.1) 12 (22.2) 0 (0) 1 (1.6) 1 (2.2) 1 (3.3) 10 (10.6) < 0.001
Caribbean 11 (3.6) 8 (14.8) 1 (4.3) 0 (0) 2 (4.4) 0 (0) 0 (0) < 0.001
Mixed and others 16 (5.2) 3 (5.5) 1 (4.3) 2 (3.2) 2 (4.4) 4 (13.3) 4 (4.2) ns
Missing 64 (20.7) 3 (5.5) 2 (8.7) 9 (14.5) 2 (4.4) 10 (33.3) 38 (40.4) < 0.001
Deprivation 28.0 ± 13.7 32.1 ± 11.4 22.5 ± 13.8 27.2 ± 13.5 30.2 ± 13.1 26.1 ± 13.3 27.1 ± 14.3 ns
Hearing Impairment 4 (1.3) 1 (1.85) 0 (0) 1 (1.6) 1 (2.2) 0 (0) 1 (1.0) ns
Visual Impairment 2 (0.6) 0 (0) 0 (0) 0 (0) 2 (4.4) 0 (0) 0 (0) ns
Mobility Impairment 8 (2.6) 4 (7.4) 0 (0) 1 (1.6) 0 (0) 1 (3.3) 2 (2.1) ns
First language English 147 (47.7) 34 (62.9) 10 (43.5) 30 (48.4) 28 (62.2) 11 (36.6) 34 (36.2) 0.008
Length of service
contact (median, days)
184 1294 292 184 513 48 0 < 0.001
Last face-to-face to
death (median, days)
70 10 19 93 31 177.5 560 < 0.001
In bold: statistically significant differences.
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19 SSD (35.2%) vs. 21 non-SSD (8.3%) (OR = 6.0, 95% CI
2.9-12.3, p < 0.001). Mean ± SD total scores were lower in
SSD (4.1 ± 2.9) compared to non-SSD (6.2 ± 2.2; t = −2.65,
p = 0.012). With regard to individual items, patients who
had SSD receiving a full risk assessment were less likely to
be recorded as having ‘suicidal ideation’, ‘hopelessness’, ‘lack
of control over life’, ‘impulsivity’ or a ‘significant loss’; while
‘disengagement’ was more common in individuals with
SSD at borderline statistical significance.
Discussion
Principal findings
In a large clinical case register sourced from electronic
mental health records linked to a national death certifica-
tion database, we investigated characteristics of patients
dying from suicide, comparing these between those with
and without SSD. Four major conclusions can be drawn
from our results.
First, a population of secondary mental healthcare users
who ended their lives over the study period (2007–2011)
was identified from our case register. Nearly one in five
of the suicide completers had been diagnosed with
schizophrenia spectrum disorders (SSD), which is ap-
proximately double that in previous reports [8], although
this may reflect the high prevalence of psychotic disorders
in South-East London [34] and our methodology does not
permit us to calculate a suicide rate in each diagnostic
category.
Second, several differences were found in sociodemo-
graphic characteristics between SSD and other diagnoses.
Specifically, those subjects with SSD died at a younger
age, they tended to be more commonly of Black origin
and they were more socially deprived than non-SSD
suicide completers, which replicated previous findings
in our catchment area with non-suicide samples [35,36].
Given the study methodology, particularly the lack of a
control non-suicide group, no causality conclusions can
be inferred from the above findings. Thus, while some
previous studies have shown an association between
psychosis and Black ethnicity [34], other groups have
raised concerns regarding a diagnostic bias towards
psychosis in Black people [37]. However, previous studies
from our group, which carefully considered the above
potential bias in the methodology, revealed a link between
Table 4 Demographics, clinical and service use-related factors: SSD vs. non-SSD suicide completers
Total sample
308
SSD
54 (17.5)
non-SSD
254 (82.5)
OR
(95% CI)
p-value
Age at death 42.7 ± 14.0 39.3 ± 11.9 43.5 ± 14.4 0.048
Gender (males) 211 (68.5) 38 (70.3) 173 (68.1) 1.11 (0.58-2.11) 0.87
Ethnicity
White 187 (60.7) 26 (48.4) 161 (63.4) 0.54 (0.30-0.97) 0.046
Black 36 (11.7) 20 (37.0) 16 (6.3) 8.75 (4.14-18.5) < 0.001
Others 85 (27.6) 8 (14.8) 77 (30.3) 0.40 (0.18-0.88) 0.020
Deprivation 28.0 ± 13.7 32.1 ± 11.4 27.1 ± 14.0 0.010
Mobility Impairment 8 (2.6) 4 (7.4) 4 (0.01) 5.00 (1.21-5.66) 0.034
First language English 147 (47.7) 34 (62.9) 113 (44.5) 2.12 (1.15-3.88) 0.016
Length of service contact (median, days) 184 1294 81 < 0.001
Last face-to-face to death (median, days) 70 10 146 < 0.001
SSD: schizophrenia spectrum disorder; OR: odds ratio; CI: confidence interval. In bold: statistically significant differences.
Table 5 Suicide method across diagnoses
Total sample
308
Schizophrenia
spectrum disorder
54 (17.5)
Affective
psychosis
23 (7.4)
Mood
disorders
62 (20.1)
Organic/
drugs
45 (14.6)
Other
diagnoses
30 (9.7)
Diagnosis
unknown
94 (30.5)
p-value
Hanging 131 (42.5) 14 (25.9) 13 (56.5) 34 (54.8) 17 (37.7) 11 (36.6) 42 (44.6) 0.025
Drowning 21 (6.8) 5 (9.2) 2 (8.7) 5 (8.0) 1 (2.2) 2 (6.6) 6 (6.4) ns
Sharp object 9 (2.9%) 2 (3.7) 0 (0) 1 (1.6) 1 (2.2) 1 (3.3) 4 (4.2) ns
Poisoning 66 (21.4) 7 (12.9) 5 (21.7) 9 (14.5) 17 (37.7) 10 (33.3) 18 (19.1) 0.015
Jumping 56 (18.2) 17 (31.5) 3 (13.0) 13 (20.9) 3 (6.6) 5 (16.6) 15 (16.0) 0.042
Burning 3 (0.9) 2 (3.7) 0 (0) 0 (0) 0 (0) 0 (0) 1 (1.0) ns
Undetermined 22 (7.4) 7 (12.9) 0 (0) 0 (0) 6 (13.3) 1 (3.3) 8 (8.5) 0.025
SSD: schizophrenia spectrum disorder; OR: odds ratio, CI: confidence interval. In bold: statistically significant differences.
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Black Ethnicity, social deprivation and psychosis in our
catchment area [31]. Hence, our findings concerning
differences between patients with and without schizophre-
nia spectrum disorders who died by suicide in terms of
social deprivation and ethnicity might reflect specific
sociodemographic characteristics of our population irre-
spective of such a fatal outcome despite previous literature
showing a relationship between ethnicity and suicide [38].
Nevertheless, further research is warranted in this area.
Third, with regard to suicide method, we found that
while hanging was the most common suicide method in
the whole sample, patients with SSD were more likely
to have used ‘jumping’ (from an height or in front of a
vehicle) to take their lives, consistent with previous litera-
ture on ‘suicide completion and method’ [4,11,39,40]. This
may have implications for suicide prevention. Limiting
availability of lethal methods has been demonstrated to
reduce suicide rates at a population level [4]. Also,
restricting access to suicide hotspots such as heights
through safety barriers (e.g. [10]) and railway lines by
installing platform edge doors [41] has been reported
to reduce overall suicide rates at such places [42]. In
keeping with the above, no suicides by gunshot were
identified in our sample, which is likely to be due to the
restrictions to firearms access in the UK. Hence, by
linking our findings concerning suicide method and
diagnosis to previous literature there are grounds to
speculate that installation of physical barriers in brid-
ges, tall buildings and railway stations near psychiatric
hospitals may prevent patients with SSD from suicide.
Nonetheless, further research should be conducted in
this area.
Fourth, it seems that clinicians deem patients who have
SSD at greater risk of suicide and they are therefore more
likely to have received a full risk assessment, as well as
having a higher likelihood of HoNOS completion, which
Table 6 Suicide method: schizophrenia spectrum disorder (SSD) vs. non-SSD
Total sample
308
SSD
54 (17.5)
non-SSD
254 (82.5)
ORs
(95% CIs)
Fisher’s exact test p-value
Hanging 131 (25.9) 14 (25.9) 117 (46.0) 0.4 (0.2-0.7) 0.005
Poisoning 66 (21.4) 7 (12.9) 59 (23.2) 0.5 (0.2-1.1) ns
Jumping 56 (18.2) 17 (31.5) 39 (15.3) 2.5 (1.3-4.9) 0.008
Cutting 9 (2.9) 2 (3.7) 7 (2.7) 1.4 (0.3-6.7) ns
Burning 3 (0.9) 2 (3.7) 1 (0.4) 9.7 (0.9-109.4) 0.081
Drowning 21 (6.8) 5 (9.2) 16 (6.3) 1.5 (0.5-4.4) ns
Undetermined 22 (7.4) 7 (12.9) 15 (5.9) 2.4 (0.9-6.1) 0.091
SSD: schizophrenia spectrum disorder; OR: odds ratio; CI: confidence interval; ns: non-significant. In bold: statistically significant differences.
Table 7 Health of the Nation Outcome Scale (HoNOS): Completion rates, individual items and total scores comparison
in SSD and non-SSD suicide completers
Completion rate
116 (37.6%)
SSD 45
(45/54 = 83.3%)
non-SSD
69 (69/254 = 35.0%)
p < 0.001
OR = 12.89 (6.00-27.73)
Individual items p-value
Agitated behaviour 0.44 0.51 ns
Self-injury 0.18 1.03 <0.001
Drinking & Drugs 0.71 0.70 ns
Cognitive Problems 0.31 0.59 ns
Physical Illness 0.82 0.68 ns
Hallucinations/Delusions 1.22 0.29 <0.001
Depressed Mood 0.89 1.80 <0.001
Other mental problems 1.38 1.65 ns
Relationship problems 1.07 1.17 ns
Daily living 0.87 0.87 ns
Living 0.67 0.59 ns
Occupational problems 0.96 0.78 ns
Total score 9.55 10.52 ns
SSD: schizophrenia spectrum disorder; OR: odds ratio; CI: confidence interval; ns: non-significant. In bold: statistically significant differences.
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is relatively in contrast to previous literature [20]. How-
ever, the above instruments may have been completed due
to concerns raised regarding other risks such as violence
and/or self-neglect.
Interestingly, known suicide risk factors tended to be less
commonly recorded as present in those who have SSD than
in subjects with non-SSD. Of relevance, disengagement was
found to be (significantly) more frequent in SSD than non-
SSD suicide completers, however. Despite the above, half of
suicide completers with a SSD had been seen by a member
of the staff shortly before such a fatal outcome, which is in
line with previous studies showing the relative inability
of clinicians to predict imminent suicide risk in individ-
uals with SSD under their care [43].
With regard to HoNOS items in our sample of suicide
completers, while symptoms severity such as depressed
mood and ‘hallucinations & delusions’ differed across
diagnostic groups, as expected, interestingly ‘social needs’,
‘cognitive deficits’ or ‘alcohol/drugs problems’ did not
(significantly) vary between patients with SSD and without
SSD. In this regard, it could be speculated that the care
package provided to these patients by the Trust succeeded
in meeting their complex social needs and accordingly the
most recent HoNOS scores regarding social needs did not
reveal differences across the above diagnostic categories.
An alternative explanation, which could not be tested in
this study due to using a sample of suicide completers
without control group, might be that there are no asso-
ciations between (met/unmet) social needs, psychiatric
diagnosis and suicidality. In addition, we replicated the
role of ‘depression’ and history of self-injury in suicide
completion, both irrespective of diagnosis and across
the different diagnoses [44], including SSD [18,45].
Regarding classic risk factors, we replicated the role
of suicidal history and suicidal ideation, hopelessness,
impulsivity and significant loses in suicide risk irrespective
of diagnosis [44,46] being highly prevalent, although they
were more frequent in the non-SSD group.
Hence, it seems that overall suicide might be less pre-
dictable, and therefore less preventable, in patients with
SSD than in those without [18,47,48]. However, disengage-
ment was specifically more common in the SSD group
than in all-other diagnoses. Hence, there are grounds to
consider that insight, which has been associated with
adherence [49], might be a protective factor for suicide in
schizophrenia spectrum disorders [18] despite common
assertions to the contrary (see [50] for review). In addition,
stigma, which prevents patients from receiving proper care
[51], may play a relevant role in suicide risk in patients
under secondary mental health services who disengage, par-
ticularly among those with SSD [52]. Nevertheless, more
research is needed to test whether anti-stigma campaigns
can reduce suicide rates both at a population level and in
secondary mental health services users.
Strengths and limitations
This study focused on the rare outcome of suicide com-
pletion and therefore adds to previous findings from
samples of suicide attempters (e.g. [53]). Moreover, by using
a large case register linked to national mortality data, all
those patients receiving secondary mental healthcare in our
catchment area who died by suicide over 2007–2011 were
included in the study with the only exception of those who
ended their lives outside the UK. Since only a small propor-
tion of patients living in South-East London receive private
mental health care, our sample is likely to be representative.
In addition, a wide range of demographic and clinical vari-
ables, including service use-related factors and specific
scales such as HoNOS and ‘risk assessment’, were analyzed.
However, several limitations should be borne in mind
when interpreting our results. First, the sample was
formed of secondary mental health services users living
in south-east London, an inner-urban area, and results
may not generalise to people receiving mental health
input from primary care or those in rural areas. Second,
HoNOS and risk assessment ratings were available for
only a small percentage of the whole sample, and there
were clear differences between diagnoses in completion
rates. Also, we can speculate that those patients without
SSD who had HONOS and risk assessment completed
were deemed ‘at-high-risk’ patients by their clinical
teams. In addition, although just the last HONOS and
risk assessment were considered for the analyses, the
time from that assessment to dying from suicide should
be taken into account when drawing associations of
causality since risk factors evaluated by those instruments
may have changed over the study period. Hence, our
findings regarding HONOS and risk assessment ratings
differences across diagnoses should be considered cau-
tiously. In keeping with the above, it should be noted
that a wide range of variables have been taken over a
prolonged period of time, which also varies across the
study patients, who ranged from having one single
assessment to several years under secondary mental
healthcare, thus reflecting the real-world nature of our data.
However, the two main variables of interest for this study,
namely a SSD diagnosis, which has been demonstrated to
have a high diagnostic stability over time [32], and suicide
completion can be considered independent of time.
Conclusions
Our findings show that patients with SSD who end their
lives have usually been deemed by their clinicians as
being at greater need of risk assessment and accordingly
they tend to be more closely monitored, including com-
pletion of full risk assessment and HoNOS. However,
such evaluated ‘known’ risk factors for suicide appear to
be more relevant in those patients with non-SSD. More-
over, most of the individuals who had SSD included in
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this study had been seen by a mental health professional
shortly before dying by suicide, jumping being the most
common suicide method.
A successful approach for suicide prevention is likely to
require a combination of both population-level strategies
such as restricting access to lethal means and measures
focused on high-risk groups such as patients with SSD.
Specifically, our results suggest that the classic suicide risk
assessment and prevention approach in secondary mental
healthcare may have little relevance for patients with SSD.
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